THE NEW RESULT OF STUDIES OF CLINICAL AND NEUROLOGICAL COMPLICATIONS IN PATIENTS WITH POLYNEUROPATHIES OF THE ETIOLOGY COVID-19

##plugins.themes.academic_pro.article.main##

Khakimova S.Z., Abdinazarov M.K.

Abstract

Abstract: A polyneuropathy is a diffuse peripheral nerve disorder that is not confined to the distribution of a single nerve or a single limb and typically is relatively symmetrical bilaterally. One of the complications of COVID-19 is polyneuropathy (Damian Mc Namara, 2020). The most widely accepted scale for a quantitative evaluation of polyneuropathy is the National Cancer Institute -Common Toxicity Criteria score, Version 4.0 (WHO criteria: / NCI-CTC scale:) from grade 0 (mild) to grade 4 (life- threatening or degree of physical disability and mental retardation). At grade 1, moderate disturbances appear like paresthesia, mild pain. Grade 2 implies a functional disorder, moderate pain, limiting instrumental ADL. Grade 3 – severe pain, limiting self-care ADL and 4 - deterioration in the quality of daily life of patients, that is, disability (J. Majersik, V. Reddy, 2020; O Koyuncu, I. Hogue, I. Enquist, 2020).

##plugins.themes.academic_pro.article.details##

How to Cite
Khakimova S.Z., Abdinazarov M.K. (2024). THE NEW RESULT OF STUDIES OF CLINICAL AND NEUROLOGICAL COMPLICATIONS IN PATIENTS WITH POLYNEUROPATHIES OF THE ETIOLOGY COVID-19. Journal the Coryphaeus of Science, 6(1), 10–15. Retrieved from http://jtcos.ru/index.php/jtcos/article/view/189